MO-460 is a moracin-derived product that generates and accumulates SGs under hypoxic circumstances by binding and inhibiting hnRNPA2B1 and reducing HIF-1α protein production.hnRNPA2B1 has been identified as a unique molecular target in hypoxia-induced tumor survival. This evidence concerns the gene HNRNPA2B1 and neoplasm.